Puma Biotechnology Inc (PBYI), Apple Inc. (AAPL), Shire PLC (ADR) (SHPG): Top 3 Holdings of Adage Capital Partners GP LLC

Puma Biotechnology PBYI

Adage Capital Partners GP LLC is a privately owned hedge fund that provides investment to a specific pool of investors. Besides investing in different interests, the firm also launches and manages hedge funds for clients. It submitted its SEC 13F Filings on November 14, 2014, covering the quarter ended September 30, 2014. The filings show that Puma Biotechnology Inc (NYSE:PBYI), Apple Inc. (NASDAQ:AAPL), and Shire PLC (ADR) (NASDAQ:SHPG) are the top three holdings of Adage Capital Partners GP LLC.

Puma Biotechnology Inc (NYSE:PBYI) became the largest investment of Adage Capital Partners GP LLC with total investment valued at $1.36 billion. Puma Biotechnology Inc (NYSE:PBYI) is a company that develops innovative therapeutics for the treatment of different forms of cancer. The company focuses on in-licensing of drug candidates that are either undergoing or have completed the preliminary clinical testing for cancer treatment and seeks to develop them further for commercial purposes. Puma Biotechnology Inc (NYSE:PBYI) recently had its shares go down after it reported that its breast cancer drug failed mid-stage test.

Puma Biotechnology PBYI

Apple Inc. (NASDAQ:AAPL) emerged the second largest investment of the firm with investment valued at $919.1 million. Apple Inc. (NASDAQ:AAPL) is a Cupertino, California-based company that designs, manufactures, and markets computer products and related software. Besides that, the company also carries out several other operations through its subsidiaries. Some of these subsidiaries are Anobit, Beats Electronics, and FingerWorks.

Shire PLC (ADR) (NASDAQ:SHPG) was the third largest investment of Adage Capital Partners GP LLC, accounting for investment value of $846.4 million. Shire PLC (ADR) (NASDAQ:SHPG) is a global biopharmaceuticals company that markets, licenses, and develops prescription medicines. The company has raised its full year forecast as a result of its revenue growth, reporting 31% increase in sales for the third quarter, compared to the same quarter the previous year. AbbVie Inc. had earlier gone into a deal to acquire Shire PLC (ADR) (NASDAQ:SHPG), but later pulled out due to the changes in the U.S. tax system.

This article has been written by Victor Ochieng.

The 20 Best Remixes of Popular Songs that Will Make You Forget the Originals

7 Most Expensive Cities in the World

Related posts

*

*

Top

Warren Buffett's Best Picks

Warren Buffett's these stock picks will crush the market over the next 12 months. Get our report FREE by becoming a member now